Related Experiment Video
Updated: Jun 15, 2026
06:33
Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue-Resident Macrophages In Vivo in Mice
Published on: February 16, 2024
Lentiviral vectors for immunization: an inflammatory field.
Mudita Pincha1, Bala Sai Sundarasetty, Renata Stripecke
1Department of Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. pincha.mudita@mh-hannover.de
Expert Review of Vaccines
|March 12, 2010
Summary
Lentiviral vectors (LVs) are effective for reprogramming dendritic cells for vaccine development. This study reviews their current use and safety enhancements for clinical applications.
Area of Science:
- Immunology
- Virology
- Gene Therapy
Background:
- Lentiviruses are retroviruses capable of transducing both dividing and nondividing cells.
- Dendritic cells are crucial immune cells and natural targets for lentiviruses.
- Lentiviral vectors (LVs) are increasingly utilized in clinical gene therapy and vaccine development.
Purpose of the Study:
- To present the current status of lentiviral vector systems for vaccine development.
- To highlight the use of LVs for gene delivery and genetic reprogramming of dendritic cells.
- To discuss improvements in LV design for enhanced biosafety in vaccine applications.
Main Methods:
- Review of existing literature on lentiviral vector applications in vaccine development.
- Evaluation of ex vivo and in vivo (immuno)gene delivery using LV systems.
- Analysis of LV design modifications for improved biosafety.
Main Results:
- Lentiviral vectors have emerged as a robust platform for dendritic cell manipulation.
- LV systems have demonstrated efficacy in preclinical and clinical settings for vaccine strategies.
- Ongoing research focuses on enhancing the biosafety profile of LVs for therapeutic use.
Conclusions:
- Lentiviral vectors represent a promising tool for developing protective and therapeutic vaccines.
- Further optimization of LV design is crucial for ensuring clinical safety and efficacy.
- The application of LVs in dendritic cell-based immunotherapy is rapidly advancing.
